CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease [Phase 2]

This is a Phase 2 trial evaluating CNM-Au8 on neuronal redox state in Parkinson's disease. Results have been posted for the completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Clene Nanomedicine | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-05-16